The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Petmed Express Inc

Nasdaq: PETS
Last

(U.S.) $16.85

Today's change-0.04 -0.24%
Updated July 31 4:00 PM EDT. Delayed by at least 15 minutes.
 

Petmed Express Inc

Nasdaq: PETS
Last

(U.S.) $16.85

Today's change-0.04 -0.24%
Updated July 31 4:00 PM EDT. Delayed by at least 15 minutes.

Petmed Express Inc down (U.S.)$0.04

Petmed Express Inc closed lower Friday, dropping (U.S.)$0.04 or 0.24% to (U.S.)$16.85. Shares have lost 1.00% over the last five days, but have gained 17.26% over the last year to date. This security has outperformed the S&P 500 by 14.02% during the last year.

Key company metrics

  • Open(U.S.) $16.89
  • Previous close(U.S.) $16.89
  • High(U.S.) $17.08
  • Low(U.S.) $16.78
  • Bid / Ask-- / --
  • YTD % change+17.26%
  • Volume194,484
  • Average volume (10-day)284,459
  • Average volume (1-month)266,533
  • Average volume (3-month)199,603
  • 52-week range(U.S.) $12.07 to (U.S.) $18.42
  • Beta1.21
  • Trailing P/E18.63×
  • P/E 1 year forward17.05×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $0.72
  • Dividend yield4.27%
  • Trailing EPS(U.S.) $0.90
Updated July 31 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.60%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Retail - Drugs
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014
Revenue50495873
Total other revenue--------
Total revenue50495873
Gross profit17171824
Total cost of revenue33323949
Total operating expense42425365
Selling / general / administrative991216
Research & development--------
Depreciation / amortization0000
Interest expense (income), net operating--------
Unusual expense (income)002--
Other operating expenses, total--------
Operating income8848
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax8848
Income after tax5535
Income tax, total3323
Net income5535
Total adjustments to net income--------
Net income before extra. items5535
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items5535
Inc. avail. to common incl. extra. items5535
Diluted net income5535
Dilution adjustment0000
Diluted weighted average shares20202020
Diluted EPS excluding extraordinary itemsvalue per share0.250.240.140.25
Dividends per sharevalue per share0.170.170.170.17
Diluted normalized EPSvalue per share0.250.240.190.25